RecruitingNCT06578104

PULSED AF Post-Approval Study

PULSED AF Post-Approval Study, an Addendum to the PulseSelect™ PFA Global Registry


Sponsor

Medtronic Cardiac Ablation Solutions

Enrollment

580 participants

Start Date

Nov 4, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

PULSED AF PAS is a prospective, global, multi-center, non-randomized, observational trial. Subjects will be treated with the PulseSelect™ PFA System and followed through 36 months.


Eligibility

Min Age: 18 Years

Inclusion Criteria5

  • A diagnosis of recurrent symptomatic paroxysmal AF or persistent AF
  • Refractory to at least one Class I or III antiarrhythmic drug (i.e., not effective, not tolerated, or not desired)
  • Patient is ≥ 18 years of age
  • Planned pulmonary vein isolation procedure with the commercially available PulseSelect™ PFA System
  • Willing and able to comply with study requirements and give informed consent (defined as legally effective, documented confirmation of a subject's voluntary agreement to participate in this clinical study) or authorization per institution and geographical requirements

Exclusion Criteria5

  • Long-standing persistent AF (continuous AF sustained \>12 months)
  • Prior left atrial catheter or surgical ablation
  • Patient with life expectancy \< 36 months
  • Presence of a permanent pacemaker, biventricular pacemaker, loop recorder/insertable cardiac monitor (ICM), or any type of implantable cardiac defibrillator (with or without biventricular pacing function)
  • Current or anticipated participation in any other clinical trial of a drug, device, or biologic not approved by the global study manager

Interventions

DEVICEPulseSelect™ PFA system

Ablation using the PulseSelect™ PFA system


Locations(16)

University of South Florida Health (USF)

Tampa, Florida, United States

Pikeville Medical Center

Whitesburg, Kentucky, United States

Southcoast Health System

Fall River, Massachusetts, United States

Beaumont Health System

Royal Oak, Michigan, United States

Nebraska Medical Center

Omaha, Nebraska, United States

The Valley Hospital

New York, New York, United States

Northwell Health Lenox Hill Hospital

New York, New York, United States

Duke University Medical Center (DUMC)

Durham, North Carolina, United States

Bethesda North Hospital

Cincinnati, Ohio, United States

The Ohio State University Wexner Medical Center

Columbus, Ohio, United States

Mount Carmel Grove City Medical Center

Grove City, Ohio, United States

Doylestown Health Cardiology a division of Doylestown Health Physicians

Doylestown, Pennsylvania, United States

AnMed Health Center

Anderson, South Carolina, United States

Medical University of South Carolina (MUSC)

Charleston, South Carolina, United States

Texas Health Research & Education Institute

Dallas, Texas, United States

University of Virginia Medical Center

Charlottesville, Virginia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06578104


Related Trials